Value proposition

AI-based Metabolic Platform for Precision Medicine

ReviveMed, is an MIT spinout, AI-based metabolomic platform for precision medicine. Metabolites, small molecules such as glucose and cholesterol, offer crucial insights into disease, patient physiology, and immune system activity, but current platforms can only detect less than 5% of human metabolites, hindering biological discoveries. We have developed the most advanced AI models capable of identifying more than 10,000 metabolite signals per patient, providing 20 times more data than any other platform. This wealth of data facilitates novel discoveries, which were not possible before.

ReviveMed partners with pharma companies while also concentrating on internal programs.


Artificial Intelligance, Machine-learning, Systems Biology, Computational Biology, and Precision Medicine